Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
This is the 2006 version of HCPCS G9096 - please refer to the 2016 HCPCS code set for the latest version.
Status changed on Sunday, January 01, 2006 to: Add procedure or modifier code
